Calamos Advisors
SRTS icon

Calamos Advisors’s Sensus Healthcare SRTS Stock Holding History

Calamos Advisors’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-60,785
Closed -$762K – 1314
2022
Q3 		$762K Buy
+60,785
New +$726K ﹤0.01% 979

Other funds holding SRTS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return

Calamos Advisors's SRTS Position: Q4 2022 in Review

Calamos Advisors sold out of Sensus Healthcare (SRTS) in Q4 2022, closing a stake of 60,785 shares — an estimated $762K sold.

Calamos Advisors first reported a position in SRTS in Q3 2022 and held it in 1 quarter. The position peaked at $762K in Q3 2022. 67 funds tracked by Wall St. Rank hold SRTS as of Q4 2022.

  • Calamos Advisors reported no remaining Sensus Healthcare position as of Q4 2022 after selling out during the quarter.
  • Calamos Advisors sold 60,785 Sensus Healthcare shares in Q4 2022, an estimated $762K.
  • Calamos Advisors first reported a position in Sensus Healthcare in Q3 2022 and held it in 1 quarter.
  • Calamos Advisors's Sensus Healthcare position peaked at $762K in Q3 2022.
  • 67 funds tracked by Wall St. Rank held Sensus Healthcare as of Q4 2022.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.